1 / 16

DEA CSOS Pilot Conference Call

DEA CSOS Pilot Conference Call. August 16, 2002. Agenda. Pilot Overview: Pilot Organization and Scope Phase II: Results Phase III: Philosophies/Goals Phase III: Accomplished Milestones Phase III: Proposed Participants Phase III: Development Options Phase III: Approach

gema
Download Presentation

DEA CSOS Pilot Conference Call

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. DEA CSOS Pilot Conference Call August 16, 2002

  2. Agenda • Pilot Overview: Pilot Organization and Scope • Phase II: Results • Phase III: Philosophies/Goals • Phase III: Accomplished Milestones • Phase III: Proposed Participants • Phase III: Development Options • Phase III: Approach • Phase III: Timeline • Phase III: Where Do We Go From Here? • Phase III: Questions…

  3. Proposed Pilot Organization and Scope

  4. Phase II: Results • A total of 27 certificates were adjudicated with 20 certificates retrieved by CSOS participants and 5 completed test plans were received from AmeriSource-Bergen, McQueary Bros., North Carolina Mutual Drug, Mallinckrodt, and McKesson. • Issues identified during testing: • Notarization of both POA and Registrant was noted as potentially difficult • Bulk enrollment for organizations practicing central ordering would be very burdensome

  5. Phase II: Results continued • Changes to DEA Anticipated Standards and enrollment processes are being developed that address these issues, affording significant time savings to the applicant. • Bulk Enrollment will be allowed • CSOS Coordinator will serve as LRA (discussed in more detail at August 20, 21 meeting)

  6. Phase III: Philosophies/Goals • Philosophies: • Divide and conquer • EDI 850-oriented, but not exclusive of other technologies • Evaluate anticipated standards • Goals • Leverage existing systems – complete gap analysis • Evaluate compatibility/impact on anticipated workflow • Identify anticipated production deployment costs • Identify cost savings - capture workflow time to complete

  7. Phase III: Accomplished Milestones • Milestones: • 850 Transaction Sets Worksheets • 850 committee decision on signature approach (external to orders vs. wrapped around orders) • Future Process Flow Draft • HDMA Survey to determine platforms planned and presently in use • Pilot participants surveyed to determine trading partnerships/roles for Phase III testing. • Work In Progress: • Test framework under development.

  8. Phase III: Proposed Participants

  9. Phase III: Participants continued

  10. Phase III: Proposed Participants continued • Endo will test revised enrollment process (CSOS Coordinator). • Wal-mart testing bulk enrollments. Anyone else interested in testing automated bulk enrollment process (we can provide a VB script)? • Capital Returns– Test Returns with McQuery Bros.?

  11. Phase III Development Options: • Option One: Work with vendor/existing infrastructure • Advantages: • Leverages existing infrastructure and tools – quicker time from test to implementation • ID gaps in current implementation • Disadvantages: • Availability of vendor software? • Option Two: Develop own code to generate or receive/validate 850. • Advantages: • Some code available that can be “tweaked” • Disadvantages: • Not working with existing infrastructure – may not get good idea of implementation costs • Option Three: Hybrid

  12. Phase III: Approach • Divide workflow into teams • Select areas to work with partner • Team A: Purchaser: • Test Objective 1: Key Exchange Process • Test Objective 2: E-222 Generation Process • Test Objective 3: Transmission Process • Test Objective 6: Receiving Process • Team B: Supplier: • Test Objective 4: E-222 Receipt Process • Test Objective 5: Order Validation Process

  13. Phase III Timeline

  14. Phase III: Where Do We Go From Here? • Certificate Extension Revisions • Changes made to facilitate automatic certificate validation. • Download new certificate – simple 5 minute process - detailed instructions will be provided. • Developer’s will need certificate profile/extension information – will email and distribute at next week’s conference. • All “Purchasers” need revised certificate

  15. Phase III: Where Do We Go From Here? • Distribute Revised Test Objectives/Test Framework next week (Margaret) • Teams work with partners/vendors to develop project plan (plan of attack). • Which process(es) will you test? • What tools will you use? • What approach will you take? • Submit project plan to mleary@pec.com by Sept. 13, 2002. • Compiled results distributed to group/teleconference to discuss approx. Sept. 30, 2002

  16. Questions

More Related